OMEROS Trademark

Trademark Overview


On Thursday, November 10, 2022, a trademark application was filed for OMEROS with the United States Patent and Trademark Office. The USPTO has given the OMEROS trademark a serial number of 97672486. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, September 5, 2024. This trademark is owned by Omeros Corporation. The OMEROS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical information services, namely, providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceutical products with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders

Providing information concerning medical and scientific research with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders
omeros

General Information


Serial Number97672486
Word MarkOMEROS
Filing DateThursday, November 10, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, September 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements


Goods and ServicesMedical information services, namely, providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceutical products with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders
Goods and ServicesProviding information concerning medical and scientific research with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOmeros Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Party NameOmeros Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events


Event DateEvent Description
Monday, November 14, 2022NEW APPLICATION ENTERED
Thursday, December 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 23, 2023ASSIGNED TO EXAMINER
Wednesday, September 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 26, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, October 16, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, December 5, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 5, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, September 5, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 5, 2024SOU EXTENSION 1 FILED
Thursday, September 5, 2024SOU EXTENSION 1 GRANTED
Thursday, September 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED